These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 7925838
21. Action of locally administered NMDA and AMPA/kainate receptor antagonists in spinal cord injury. Li S, Tator CH. Neurol Res; 2000 Mar; 22(2):171-80. PubMed ID: 10763505 [Abstract] [Full Text] [Related]
22. Excessive release of [3H]noradrenaline and glutamate in response to simulation of ischemic conditions in rat spinal cord slice preparation: effect of NMDA and AMPA receptor antagonists. Nakai T, Milusheva E, Baranyi M, Uchihashi Y, Satoh T, Vizi ES. Eur J Pharmacol; 1999 Feb 05; 366(2-3):143-50. PubMed ID: 10082194 [Abstract] [Full Text] [Related]
23. Pharmacological characterization of AMPA-induced biting behaviour in mice. Brambilla A, Prudentino A, Grippa N, Borsini F. Eur J Pharmacol; 1996 Jun 03; 305(1-3):115-7. PubMed ID: 8813540 [Abstract] [Full Text] [Related]
24. Protection against ischemic hippocampal CA1 damage in the rat with a new non-NMDA antagonist, NBQX. Diemer NH, Jørgensen MB, Johansen FF, Sheardown M, Honoré T. Acta Neurol Scand; 1992 Jul 03; 86(1):45-9. PubMed ID: 1325729 [Abstract] [Full Text] [Related]
25. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. Willis CL, Meldrum BS, Nunn PB, Anderton BH, Leigh PN. Brain Res; 1993 Nov 05; 627(1):55-62. PubMed ID: 7507397 [Abstract] [Full Text] [Related]
26. Potentiation of MK-801-induced breathing impairment by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. McManigle JE, Taveira DaSilva AM, Dretchen KL, Gillis RA. Eur J Pharmacol; 1994 Jan 24; 252(1):11-7. PubMed ID: 8149990 [Abstract] [Full Text] [Related]
27. NMDA and non-NMDA receptor gene expression following global brain ischemia in rats: effect of NMDA and non-NMDA receptor antagonists. Pellegrini-Giampietro DE, Pulsinelli WA, Zukin RS. J Neurochem; 1994 Mar 24; 62(3):1067-73. PubMed ID: 8113793 [Abstract] [Full Text] [Related]
28. The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. Lauritzen M, Hansen AJ. J Cereb Blood Flow Metab; 1992 Mar 24; 12(2):223-9. PubMed ID: 1312539 [Abstract] [Full Text] [Related]
29. The AMPA antagonist NBQX protects thalamic reticular neurons from degeneration following cardiac arrest in rats. Ross DT, Brasko J, Patrikios P. Brain Res; 1995 Jun 12; 683(1):117-28. PubMed ID: 7552336 [Abstract] [Full Text] [Related]
30. Differential effect of NMDA and AMPA receptor blockade on protein synthesis in the rat infarct borderzone. Christensen T, Bruhn T, Frank L, Diemer NH. Acta Neurol Scand; 1996 Jun 12; 93(2-3):160-7. PubMed ID: 8741137 [Abstract] [Full Text] [Related]
31. Alteration in sensitivity of ionotropic glutamate receptors and tachykinin receptors in spinal cord contribute to development and maintenance of nerve injury-evoked neuropathic pain. Yoshimura M, Yonehara N. Neurosci Res; 2006 Sep 12; 56(1):21-8. PubMed ID: 16901566 [Abstract] [Full Text] [Related]
32. No protective effect of the NMDA antagonist memantine in experimental spinal cord injuries. von Euler M, Li-Li M, Whittemore S, Seiger A, Sundström E. J Neurotrauma; 1997 Jan 12; 14(1):53-61. PubMed ID: 9048311 [Abstract] [Full Text] [Related]